基于 2 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the full record of transactions filed by Alton Gregg H, 董事. Director active across 1 company, notably NOVAVAX INC. Aggregated, 5 reports have been published. History available since 12 June 2024. The latest transaction was filed on 31 March 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Gregg H. Alton is a Board Member at NOVAVAX INC. He is involved in the governance of the company and actively participates in defining its strategy. With his experience in the pharmaceutical sector, he contributes to informed decision-making that promotes growth and innovation.